pasc

  1. C

    Defining post-acute COVID-19 syndrome (PACS) by an epigenetic biosignature in peripheral blood mononuclear cells (Nikesjo et al, 2022)

    Abstract Post-acute COVID-19 syndrome (PACS) has been defined as symptoms persisting after clearance of a COVID-19 infection. We have previously demonstrated that alterations in DNA methylation (DNAm) status persist in individuals who recovered from a COVID-19 infection, but it is currently...
  2. C

    Preprint: Impact of cross-coronavirus immunity in post-acute sequelae of COVID-19 (Herman et al, 2022)

    Abstract Beyond the unpredictable acute illness caused by SARS-CoV-2, one-fifth of infections unpredictably result in long-term persistence of symptoms despite the apparent clearance of infection. Insights into the mechanisms that underlie post-acute sequelae of COVID-19 (PASC) will be critical...
  3. C

    Targeting the Monocytic-Endothelial-Platelet Axis with Maraviroc and Pravastatin as a Therapeutic Option to Treat Long COVID...(Patterson et al, 2022)

    Targeting the Monocytic-Endothelial-Platelet Axis with Maraviroc and Pravastatin as a Therapeutic Option to Treat Long COVID/ Post-Acute Sequelae of COVID (PASC) Bruce Patterson et al, 2022 Abstract Post-acute sequelae of COVID (PASC), or long COVID, is a multisystem complication of...